Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Technoclone is a world-leading developer and manufacturer of in vitro diagnostic tests, reagents, and automated analyzers focused on haemostasis, fibrinolysis, and cardiovascular diseases. Its product portfolio includes global and specialty coagulation tests (PT, aPTT, thrombin time, fibrinogen), ELISA systems, control and reference plasmas, and fully automated analyzers for routine and research applications. The company is known for innovation in coagulation diagnostics, holding multiple international patents, and collaborates with academic and industrial partners worldwide[1][3][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Technoclone.